← Back to Search

Extended Depth of Focus IOL

Vivity IOL: Emmetropia Compared to Monovision.

Mount Pleasant, SC
N/A
Waitlist Available
Led By Kerry Solomon
Research Sponsored by Carolina Eyecare Physicians, LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
No Placebo-Only Group

Summary

Current visual outcomes expectations of cataract patients are similar to those of refractive surgery patients. Their desire is to be spectacle independent for far, intermediate and near vision activities. Different options are available including: mono-vision and presbyopia correcting intraocular lenses (IOL). Presbyopia correcting IOLs include accommodative, multifocal, trifocal and extended depth of focus (EDOF) IOLs. The Vivity Extended Vision IOL is not a multifocal IOL but due to its design, it provides better intermediate and near VA compared to a monofocal IOL.

See full description
Eligible Conditions
  • Presbyopia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Binocular uncorrected near (40 cm) visual acuity

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: MonovisionExperimental Treatment1 Intervention
The target refraction is plano (0.00 D) for the dominant eye and between -0.50 D and -0.75 D for the non-dominant eye. The Vivity IOL will be implanted bilaterally. Corrected vision will involve correcting the dominant eye for emmetropia and the non-dominant eye for -0.50 D.
Group II: EmmetropiaActive Control1 Intervention
Subject's vision will be tested with both eyes corrected for emmetropia.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Vivity IOL
2023
Completed Phase 4
~150

Find a Location

Closest Location:Carolina Eyecare Physicians, LLC· Mount Pleasant, SC

Who is running the clinical trial?

Science in VisionOTHER
16 Previous Clinical Trials
771 Total Patients Enrolled
3 Trials studying Presbyopia
132 Patients Enrolled for Presbyopia
Carolina Eyecare Physicians, LLCLead Sponsor
10 Previous Clinical Trials
567 Total Patients Enrolled
2 Trials studying Presbyopia
114 Patients Enrolled for Presbyopia
Kerry SolomonPrincipal InvestigatorCarolina Eyecare Physicians, LLC
1 Previous Clinical Trials
30 Total Patients Enrolled
~6 spots leftby Feb 2026